Kyverna Therapeutics, Inc. (KYTX)
Nasdaq · Biological Products, (No Diagnostic Substances) · Inc. DE
What they're doing
Between 2026-06-21 and 2026-09-19, public records show 2 signals for Kyverna Therapeutics, Inc.. Most notable: 2026-07-09: Filed 8-K disclosing material agreement; 2026-07-27: Filed 8-K disclosing material agreement. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.
Generated 2026-09-19 from public records.
Signals, last 12 months
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing director or officer change
- Material 8-K filingFiled 8-K disclosing director or officer change
- Material 8-K filingFiled 8-K disclosing director or officer change
- Material 8-K filingFiled 8-K disclosing director or officer change
- Insider buying cluster3 insiders bought $4.0M within 14 days
- Insider purchaseSEIDENBERG BETH C (director) bought $1000k of stock
- Insider purchaseWestlake BioPartners Opportunity Fund I, L.P. (ten_percent_owner) bought $1000k of stock
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing director or officer change
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-27 | Aktar Mert | director | A | 5,093 | 0 | $0 |
| 2026-05-27 | Shaw Christi | director | F | 4,194 | 8.59 | $36,026 |
| 2026-05-27 | SEIDENBERG BETH C | director | A | 5,093 | 0 | $0 |
| 2026-05-27 | Cohen Fred E | director | A | 5,093 | 0 | $0 |
| 2026-05-27 | CLARK IAN T | director | A | 5,093 | 0 | $0 |
| 2026-05-27 | CLARK IAN T | director | A | 5,093 | 0 | $0 |
| 2026-05-27 | Cohen Fred E | director | A | 5,093 | 0 | $0 |
| 2026-05-27 | SEIDENBERG BETH C | director | A | 5,093 | 0 | $0 |
| 2026-05-27 | Shaw Christi | director | F | 4,194 | 8.59 | $36,026 |
| 2026-05-27 | Aktar Mert | director | A | 5,093 | 0 | $0 |
| 2026-03-13 | GEHCHAN NAJI | officer | A | 18,000 | 0 | $0 |
| 2026-03-13 | Biddle Warner Weston | director | A | 58,000 | 0 | $0 |
| 2026-03-13 | GRASSO MARC | officer | A | 10,000 | 0 | $0 |
| 2026-03-13 | GEHCHAN NAJI | officer | A | 18,000 | 0 | $0 |
| 2026-03-13 | GRASSO MARC | officer | A | 10,000 | 0 | $0 |
| 2026-03-13 | Biddle Warner Weston | director | A | 58,000 | 0 | $0 |
| 2026-02-24 | Emany Sravan Kumar | director | A | 11,006 | 0 | $0 |
| 2026-02-24 | Miller Andrew Craig | director | A | 11,006 | 0 | $0 |
| 2026-02-24 | Miller Andrew Craig | director | A | 11,006 | 0 | $0 |
| 2026-02-24 | Emany Sravan Kumar | director | A | 11,006 | 0 | $0 |
| 2026-01-12 | Shaw Christi | director | A | 24,301 | 0 | $0 |
| 2026-01-12 | Shaw Christi | director | A | 30,000 | 0 | $0 |
| 2026-01-12 | Shaw Christi | director | A | 30,000 | 0 | $0 |
| 2026-01-12 | Shaw Christi | director | A | 24,301 | 0 | $0 |
| 2025-12-18 | Westlake BioPartners Opportunity Fund I, L.P.; Westlake BioPartners Opportunity GP I, LLC; Westlake BioPartners Fund I, L.P.; Westlake BioPartners GP I, LLC | ten percent owner | P | 133,333 | 7.5 | $999,998 |
| 2025-12-18 | SEIDENBERG BETH C | director | P | 133,333 | 7.5 | $999,998 |
| 2025-12-18 | SEIDENBERG BETH C | director | P | 133,333 | 7.5 | $999,998 |
| 2025-12-18 | Westlake BioPartners Opportunity Fund I, L.P. | ten percent owner | P | 133,333 | 7.5 | $999,998 |
| 2025-12-15 | Walker Karen Marie | officer | S | 23,998 | 12.2 | $292,776 |
| 2025-12-15 | Walker Karen Marie | officer | M | 23,998 | 4.83 | $115,910 |
| 2025-12-15 | Walker Karen Marie | officer | M | 23,998 | 4.83 | $115,910 |
| 2025-12-15 | Walker Karen Marie | officer | S | 23,998 | 12.2 | $292,776 |
| 2025-05-29 | Cohen Fred E | director | A | 16,634 | 0 | $0 |
| 2025-05-29 | CLARK IAN T | director | A | 16,634 | 0 | $0 |
| 2025-05-29 | Aktar Mert | director | A | 16,634 | 0 | $0 |
| 2025-05-29 | SPIEGELMAN DANIEL K | director | A | 16,634 | 0 | $0 |
| 2025-05-29 | SEIDENBERG BETH C | director | A | 16,634 | 0 | $0 |
| 2025-05-29 | Shaw Christi | director | A | 16,634 | 0 | $0 |
| 2025-05-29 | Shaw Christi | director | A | 16,634 | 0 | $0 |
| 2025-05-29 | SEIDENBERG BETH C | director | A | 16,634 | 0 | $0 |
| 2025-05-29 | SPIEGELMAN DANIEL K | director | A | 16,634 | 0 | $0 |
| 2025-05-29 | Aktar Mert | director | A | 16,634 | 0 | $0 |
| 2025-05-29 | CLARK IAN T | director | A | 16,634 | 0 | $0 |
| 2025-05-29 | Cohen Fred E | director | A | 16,634 | 0 | $0 |
| 2025-04-11 | Walker Karen Marie | officer | A | 13,000 | 0 | $0 |
| 2025-04-11 | Jones Ryan Alexander | officer | A | 12,000 | 0 | $0 |
| 2025-04-11 | Jones Ryan Alexander | officer | A | 12,000 | 0 | $0 |
| 2025-04-11 | Walker Karen Marie | officer | A | 13,000 | 0 | $0 |
| 2024-06-06 | Walker Karen Marie | officer | M | 9,636 | 4.42 | $42,591 |
| 2024-05-28 | Jones Ryan Alexander | officer | M | 7,146 | 0.73 | $5,217 |
Federal contracts
No federal contract actions on record for this recipient mapping.
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
No Wikipedia pageview data linked to this company.